EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand


Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand



Life Sciences 42(2): 179-187



ISSN/ISBN: 0024-3205

PMID: 2892106

DOI: 10.1016/0024-3205(88)90681-9

Quazepam and 2-oxo-quazepam are novel benzodiazepines containing a trifluoroethyl substituent on the ring nitrogen at position #1. Detailed competition binding experiments (25 to 30 concs.) at 4 degrees C were undertaken with these compounds versus 3H-flunitrazepam using synaptic membranes from rat cortex or cerebellum. Unlike other benzodiazepines, both quazepam and 2-oxo-quazepam distinguished two populations of 3H-flunitrazepam binding sites in rat cortex which were present in roughly equal proportions and for which the compounds displayed a greater than 20-fold difference in affinity. In cerebellum, no such discrimination of sites was noted for 2-oxo-quazepam, but quazepam did distinguish a small, low affinity (15% of total) population of sites. 3H-2-oxo-quazepam was prepared and used in competition studies to substantiate the conclusion that these compounds discriminate two populations of benzodiazepine sites in rat cortex. This new radioligand was shown to specifically label BZ binding sites with high affinity in a saturable manner. The competition experiments were then conducted using 3H-2-oxo-quazepam at a radioligand concentration sufficiently low (0.5 nM) to ensure that only the higher affinity binding sites which 2-oxo-quazepam discriminates would be occupied. Competition experiments in both cortex and cerebellum under these conditions indicated single site binding for unlabelled quazepam and 2-oxo-quazepam in every instance. This suggests that 3H-2-oxo-quazepam should be a useful new tool for selectively labeling and studying the BZ1 population of benzodiazepine binding sites.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041321826

Download citation: RISBibTeXText

Related references

Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and 3 demonstration of H-2-oxo-quazepam as a BZ1 selective radioligand. Life Sciences (1973) 42(2): 179-187, 1988

Selective affinity of the benzodiazepines quazepam and 2 oxoquazepam for bz1 binding site and demonstration of tritiated 2 oxoquazepam as a bz1 selective radioligand. Life Sciences 42(2): 179-188, 1988

Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam. Pharmaceutical Research 5(6): 365-368, 1988

Detailed receptor binding studies with the benzodiazepine quazepam and its 2 oxo metabolite novel bz 1 selective ligands. Society for Neuroscience Abstracts 12(1): 17, 1986

Use of the selective benzodiazepine-1 (BZ-1) ligand [3H]2-oxo-quazepam (SCH 15-725) to localize BZ-1 receptors in the rat brain. Neuroscience Letters 88(1): 86-92, 1988

Quazepam, a sedative-hypnotic selective for the benzodiazepine type 1 receptor: autoradiographic localization in rat and human brain. Clinical Neuropharmacology 8(Suppl): S26-S40, 1985

Different effects of light food on pharmacokinetics and pharmacodynamics of three benzodiazepines, quazepam, nitrazepam and diazepam. Journal of Clinical Pharmacy and Therapeutics 32(1): 31-39, 2007

Relative affinity of quazepam for type-1 benzodiazepine receptors in brain. Journal of Clinical Psychiatry 52(Suppl): 15-20, 1991

Enhancement of gamma-aminobutyric acid binding by quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors. Journal of Neurochemistry 47(2): 370-374, 1986

Characterization of 3H-2-oxo-quazepam binding in the human brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 12(5): 701-712, 1988

Preferential affinity of 3H-2-oxo-quazepam for type I benzadiazepine recognition sites in the human brain. Life Sciences (1973) 42(2): 189-197, 1988

Preferential affinity of 3H-2-oxo-quazepam for type I benzodiazepine recognition sites in the human brain. Life Sciences 42(2): 189-197, 1988

Quazepam and 2 oxoquazepam are the most effective benzodiazepine bz receptor ligands as inhibitors of sulfur 35 tbps binding in the rat brain. Society for Neuroscience Abstracts 14(1): 448, 1988

Quazepam. Drugs of the Future 3(2): 139-141, 1978

Quazepam for insomnia. Nursing 21(4): 118, 1991